
The Biotech Growth Trust PLC – LSE:BIOG.L
The Biotech Growth Trust stock price today
The Biotech Growth Trust stock price monthly change
The Biotech Growth Trust stock price quarterly change
The Biotech Growth Trust stock price yearly change
The Biotech Growth Trust key metrics
Market Cap | 264.81M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -2.32 |
Revenue | -87.65M |
EBITDA | -391K |
Income | -92.02M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 0.45% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeThe Biotech Growth Trust stock price history
The Biotech Growth Trust stock forecast
The Biotech Growth Trust financial statements
Dec 2022 | -38.61M | -39.14M | 101.38% |
---|---|---|---|
Mar 2023 | -38.61M | -39.14M | 101.38% |
Jun 2023 | -5.21M | -6.86M | 131.67% |
Sep 2023 | -5.21M | -6.86M | 131.67% |
Dec 2022 | 360509000 | 30.21M | 8.38% |
---|---|---|---|
Jun 2023 | 308211000 | 14.79M | 4.8% |
Sep 2023 | 308211000 | 11.43M | 3.71% |
Mar 2024 | 411420000 | 50.11M | 12.18% |
Dec 2022 | -2.03M | 11.35M | -7.92M |
---|---|---|---|
Mar 2023 | -2.03M | 11.35M | -7.92M |
Jun 2023 | -936K | 18.01M | -16.90M |
Sep 2023 | -936K | 18.01M | -16.90M |
The Biotech Growth Trust other data
-
What's the price of The Biotech Growth Trust stock today?
One share of The Biotech Growth Trust stock can currently be purchased for approximately $1,188.
-
When is The Biotech Growth Trust's next earnings date?
Unfortunately, The Biotech Growth Trust's (BIOG.L) next earnings date is currently unknown.
-
Does The Biotech Growth Trust pay dividends?
No, The Biotech Growth Trust does not pay dividends.
-
How much money does The Biotech Growth Trust make?
The Biotech Growth Trust has a market capitalization of 264.81M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 138.31% to 80.35M US dollars.
-
What is The Biotech Growth Trust's stock symbol?
The Biotech Growth Trust PLC is traded on the LSE under the ticker symbol "BIOG.L".
-
What is The Biotech Growth Trust's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of The Biotech Growth Trust?
Shares of The Biotech Growth Trust can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When The Biotech Growth Trust went public?
The Biotech Growth Trust PLC is publicly traded company for more then 28 years since IPO on 23 Jun 1997.
-
What is The Biotech Growth Trust's official website?
The official website for The Biotech Growth Trust is biotechgt.com.
-
Where are The Biotech Growth Trust's headquarters?
The Biotech Growth Trust is headquartered at 601 Lexington Avenue, New York, NY.
-
How can i contact The Biotech Growth Trust?
The Biotech Growth Trust's mailing address is 601 Lexington Avenue, New York, NY and company can be reached via phone at +212 7396400.
The Biotech Growth Trust company profile:

The Biotech Growth Trust PLC
biotechgt.comLSE
0
Asset Management
Financial Services
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
New York, NY 10022
:
ISIN: GB0000385517
CUSIP: G1281H103